Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The...
With the second wave of Covid-19 infections putting pressure on India's healthcare infrastructure, top doctors comment on how the government can update its vaccination strategy. Doctors Jalil Parkar and Amit Thadhani spoke on the need to widen the vaccination net, and also include the private sector to a greater degree. Watch the full video for more.
Credit: HT Digital Content Duration: 03:44Published
Relatives of patients admitted to Delhi hospitals for Covid-19 treatment recounted their ordeal amid an unprecedented surge in cases. The patients' relatives said they found admission after being rejected by multiple hospitals. One of them claimed that 4 people were being housed on a single bed, while another stated that her relative had been asked to lie down on the floor, and was being denied food and water. Delhi saw 25,500+ new Covid cases in 24 hours, the highest single-day surge so far. Watch the full video for more.
Credit: HT Digital Content Duration: 02:15Published
Germany, represented by Chancellor Angela Merkel and President Frank-Walter Steinmeier, holds a national memorial service in a Berlin concert hall for its nearly 80,000 victims of the coronavirus pandemic.
Credit: euronews (in English) Duration: 01:00Published
The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and.. IndiaTimes
The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As.. IndiaTimes
The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."
Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and.. IndiaTimes
![Time to put vaccines at medical stores to beat Covid wave? Top doctors answer [Video]](https://video.newsserve.net/300/v/20210418/2104181624-Time-to-put-vaccines-at-medical-stores-to.jpg)
!['4 people on 1 bed': Patients' relatives on ordeal at Delhi hospitals | Covid [Video]](https://video.newsserve.net/300/v/20210418/2104181550-people-on-bed-Patients-relatives.jpg)
![Germany mourns its 80,000 Covid dead at memorial [Video]](https://video.newsserve.net/300/v/20210418/1318726771-Germany-mourns-its-80-000-Covid-dead-at.jpg)
![Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]](https://video.newsserve.net/300/v/20210416/2104160714-Mumbai-Haffkine-Institute-gets-Centre-nod.jpg)
